BIOW
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BIOW - overview
Established
2012
Location
Gijon, -, Spain
Primary Industry
Biotechnology
About
Based in Asturias, Spain, and co-founded by Pedro Llana and Alejandro Loredo in 2012, Biow Exposomic SL doing business as BIOW operates as a MedTech company that specializes in developing research projects such as oxidative stress and cell regeneration. In April 2023, the firm raised EUR 5 million in venture funding led by investor Mundi Ventures. The company specializes in developing and producing active preventive medicine solutions for promoting healthy living. The company’s flagship product bioenergetic antioxidant chamber, made by using cold atmospheric plasma medical technology, is designed to help users reduce oxidative stress, enhance their immune system, increase energy, increase protein synthesis and methionine cycle, and fight the visible signs of aging.
The chamber uses bioenergetic technology to create an environment that promotes the natural healing processes of the human body. BIOW also offers a product called bioenergy inducer, a small size equipment designed to improve breathing and deep oxygenation, CRU (Cellular Regeneration Unit) for home use, focused on enhancing the effects of sleep, and e-health programs to improve breathing, circulation, and rest.
Current Investors
Mundi Ventures
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Medical Devices & Equipment
Website
www.biow.es
Verticals
Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.